The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADICET BIO INC | COM | 007002108 | 5,559 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,869 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 8,420 | 1,409,150 | SH | SOLE | 1,409,150 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 6,891 | 104,253 | SH | SOLE | 104,253 | 0 | 0 | ||
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | 55,803 | 903,688 | SH | SOLE | 903,688 | 0 | 0 | ||
| BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 9,469 | 287,725 | SH | SOLE | 287,725 | 0 | 0 | ||
| CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 23,734 | 1,728,590 | SH | SOLE | 1,728,590 | 0 | 0 | ||
| UNUM THERAPEUTICS INC | COM | 19240Q201 | 14,246 | 1,622,591 | SH | SOLE | 1,622,591 | 0 | 0 | ||
| CASTLE BIOSCIENCES INC | COM | 14843C105 | 6,846 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CUREVAC N V | COM | N2451R105 | 10,061 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| ESSA PHARMA INC | COM NEW | 29668H708 | 10,551 | 363,185 | SH | SOLE | 363,185 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 22,262 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 6,507 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| FREELINE THERAPEUTICS HLDGS | SPONSORED ADS | 35655L107 | 5,027 | 408,726 | SH | SOLE | 408,726 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 705 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 4,170 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 12,885 | 406,986 | SH | SOLE | 406,986 | 0 | 0 | ||
| ITAMAR MED LTD | SPONSORED ADS | 465437101 | 6,552 | 273,569 | SH | SOLE | 273,569 | 0 | 0 | ||
| ITEOS THERAPEUTICS INC | COM | 46565G104 | 11,033 | 322,794 | SH | SOLE | 322,794 | 0 | 0 | ||
| PULMONX CORP | COM | 745848101 | 2,696 | 58,939 | SH | SOLE | 58,939 | 0 | 0 | ||
| MEDAVAIL HOLDINGS INC | COM | 58406B103 | 40,891 | 2,920,780 | SH | SOLE | 2,920,780 | 0 | 0 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 18,057 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | 22,136 | 218,000 | SH | SOLE | 218,000 | 0 | 0 | ||
| NUVATION BIO INC | COM CL A | 67080N101 | 20,900 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| OLINK HLDG AB | SPONSORED ADS | 680710100 | 7,200 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 10,120 | 413,061 | SH | SOLE | 413,061 | 0 | 0 | ||
| ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 3,974 | 547,427 | SH | SOLE | 547,427 | 0 | 0 | ||
| REPLIGEN CORP | COM | 759916109 | 16,039 | 82,500 | SH | SOLE | 82,500 | 0 | 0 | ||
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 5,610 | 128,572 | SH | SOLE | 128,572 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 23,486 | 3,139,895 | SH | SOLE | 3,139,895 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 11,376 | 680,768 | SH | SOLE | 680,768 | 0 | 0 | ||
| SPDR SER TR | PUT | 78464A950 | 108,520 | 800,000 | SH | Put | SOLE | 800,000 | 0 | 0 | |